RUA Life Sciences (LON:RUA) Stock Price Up 6.3% – Should You Buy?

RUA Life Sciences plc (LON:RUA) shares traded up 6.3% during trading on Friday. The stock traded as high as GBX 31 and last traded at GBX 29.22. 348,834 shares were traded during trading, an increase of 61% from the average daily volume of 216,106 shares. The stock had previously closed at GBX 27.50.

RUA Life Sciences Price Performance

The firm has a fifty day moving average of GBX 26.28 and a two-hundred day moving average of GBX 21.05. The stock has a market capitalization of £18.13 million, a P/E ratio of -2.61 and a beta of 0.99. The company has a debt-to-equity ratio of 18.95, a current ratio of 4.64 and a quick ratio of 7.32.

RUA Life Sciences (LON:RUA) last issued its quarterly earnings data on Tuesday, June 30th. The company reported GBX (0.33) earnings per share for the quarter. RUA Life Sciences had a negative return on equity of 2.03% and a negative net margin of 3.26%.

RUA Life Sciences Company Profile

The RUA Life Sciences group was created in April 2020 when AorTech International plc acquired RUA Medical Devices Ltd to create a fully formed medical device business. RUA Life Sciences is the holding company of the group trading through four businesses all exploiting the group’s polymer technology. Our vision is to improve the lives of millions of patients by improving and enabling medical devices with Elast-EonTM, the worlds leading long term implantable polyurethane.